Skip to content

Advertisement

BMC Neurology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report

BMC NeurologyBMC series – open, inclusive and trusted201616:197

https://doi.org/10.1186/s12883-016-0720-2

Received: 2 July 2016

Accepted: 14 October 2016

Published: 18 October 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Jul 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Oct 2016 Editorially accepted
18 Oct 2016 Article published 10.1186/s12883-016-0720-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurology, Akershus University Hospital, Lørenskog, Norway
(2)
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
(3)
Multiple Sclerosis Centre Hakadal, Hakadal, Norway
(4)
Department of Radiology, Akershus University Hospital, Lørenskog, Norway
(5)
Department of Neurology, Oslo University Hospital Rikshospitalet, Oslo, Norway

Advertisement